Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	ubiquitin-modified histone reader activity	RNF169 DNAJC2 JARID2	2.58e-05	7	183	3	GO:0061649
GeneOntologyMolecularFunction	MutLalpha complex binding	WRN MSH2 MSH6	2.58e-05	7	183	3	GO:0032405
GeneOntologyMolecularFunction	DNA secondary structure binding	MAPT WRN MSH2 RAD51AP1 MSH6	3.51e-05	41	183	5	GO:0000217
GeneOntologyMolecularFunction	ubiquitin-like protein reader activity	RNF169 DNAJC2 JARID2 PML	7.43e-05	25	183	4	GO:0140035
GeneOntologyMolecularFunction	single thymine insertion binding	MSH2 MSH6	8.35e-05	2	183	2	GO:0032143
GeneOntologyMolecularFunction	P-type sodium transporter activity	ATP1A1 ATP1A3 ATP12A	8.67e-05	10	183	3	GO:0008554
GeneOntologyMolecularFunction	P-type sodium:potassium-exchanging transporter activity	ATP1A1 ATP1A3 ATP12A	8.67e-05	10	183	3	GO:0005391
GeneOntologyMolecularFunction	oxidized purine DNA binding	WRN MSH2 MSH6	8.67e-05	10	183	3	GO:0032357
GeneOntologyMolecularFunction	P-type potassium transmembrane transporter activity	ATP1A1 ATP1A3 ATP12A	1.18e-04	11	183	3	GO:0008556
GeneOntologyMolecularFunction	mismatch repair complex binding	WRN MSH2 MSH6	1.18e-04	11	183	3	GO:0032404
GeneOntologyMolecularFunction	oxidized DNA binding	WRN MSH2 MSH6	1.18e-04	11	183	3	GO:0032356
GeneOntologyMolecularFunction	ATP-dependent activity	SETX MYO9A MYO10 WRN RNF213 CHD1 MSH2 ATP9A MSH6 DDX46 KIF4B ATP13A3 ATP1A1 ATP1A3 ATP12A KIF13A	1.76e-04	614	183	16	GO:0140657
GeneOntologyMolecularFunction	cytoskeletal protein binding	SHROOM3 CTTNBP2 ANK3 MAP4 PSG5 MYO9A MAPT MYO10 FSCN3 OBSCN SPATA31C1 PTPRT CEP350 CCDC66 EGFR TTLL4 TLN1 TLN2 KIF4B SSH2 ATP1A1 KIF13A USH2A	1.87e-04	1099	183	23	GO:0008092
GeneOntologyMolecularFunction	single guanine insertion binding	MSH2 MSH6	2.49e-04	3	183	2	GO:0032142
GeneOntologyMolecularFunction	P-type transmembrane transporter activity	ATP13A3 ATP1A1 ATP1A3 ATP12A	3.20e-04	36	183	4	GO:0140358
GeneOntologyMolecularFunction	P-type ion transporter activity	ATP13A3 ATP1A1 ATP1A3 ATP12A	3.20e-04	36	183	4	GO:0015662
GeneOntologyMolecularFunction	guanine/thymine mispair binding	MSH2 MSH6	4.95e-04	4	183	2	GO:0032137
GeneOntologyMolecularFunction	single base insertion or deletion binding	MSH2 MSH6	4.95e-04	4	183	2	GO:0032138
GeneOntologyMolecularFunction	four-way junction DNA binding	WRN MSH2 MSH6	6.59e-04	19	183	3	GO:0000400
GeneOntologyMolecularFunction	ubiquitin-modified protein reader activity	RNF169 DNAJC2 JARID2	7.70e-04	20	183	3	GO:0140036
GeneOntologyMolecularFunction	histone H3K9me/H3K9me2 demethylase activity	KDM3A KDM3B	8.20e-04	5	183	2	GO:0140683
GeneOntologyMolecularFunction	beta-N-acetylhexosaminidase activity	CHIA OGA	1.22e-03	6	183	2	GO:0004563
GeneOntologyMolecularFunction	D-loop DNA binding	WRN RAD51AP1	1.22e-03	6	183	2	GO:0062037
GeneOntologyMolecularFunction	DNA insertion or deletion binding	MSH2 MSH6	1.22e-03	6	183	2	GO:0032135
GeneOntologyMolecularFunction	histone reader activity	RNF169 DNAJC2 JARID2	1.69e-03	26	183	3	GO:0140566
GeneOntologyMolecularFunction	centromeric DNA binding	CENPC MSH2	1.70e-03	7	183	2	GO:0019237
GeneOntologyMolecularFunction	steroid hormone binding	ATP1A1 ATP1A3	1.70e-03	7	183	2	GO:1990239
GeneOntologyMolecularFunction	ATPase-coupled monoatomic cation transmembrane transporter activity	ATP13A3 ATP1A1 ATP1A3 ATP12A	2.52e-03	62	183	4	GO:0019829
GeneOntologyMolecularFunction	ATP hydrolysis activity	WRN RNF213 CHD1 MSH2 ATP9A DDX46 ATP13A3 ATP1A1 ATP1A3 ATP12A KIF13A	2.57e-03	441	183	11	GO:0016887
GeneOntologyBiologicalProcess	DNA repair	RNF169 SETX SLF1 WRN MSH2 TEX15 TRIP12 CDC7 RAD51AP1 FANCB MSH6 KIN WDHD1 EGFR TNKS1BP1 BOD1L1 ATM USP1 SLX4 PML	1.36e-06	648	183	20	GO:0006281
GeneOntologyBiologicalProcess	positive regulation of DNA metabolic process	SLF1 WRN MSH2 CDC7 MET RAD51AP1 FANCB EGFR TINF2 ATM OGA USP1 SLX4 PML	1.74e-06	333	183	14	GO:0051054
GeneOntologyBiologicalProcess	regulation of DNA metabolic process	RNF169 SLF1 WRN MSH2 TEX15 DNAJC2 CDC7 MET RAD51AP1 FANCB MSH6 EGFR TINF2 ATM OGA USP1 SLX4 PML	2.98e-06	564	183	18	GO:0051052
GeneOntologyBiologicalProcess	double-strand break repair	RNF169 SETX SLF1 WRN MSH2 TEX15 CDC7 RAD51AP1 FANCB TNKS1BP1 ATM SLX4 PML	6.84e-06	324	183	13	GO:0006302
GeneOntologyBiologicalProcess	negative regulation of DNA metabolic process	RNF169 MSH2 DNAJC2 FANCB MSH6 TINF2 ATM SLX4 PML	1.03e-05	155	183	9	GO:0051053
GeneOntologyBiologicalProcess	DNA damage response	RNF169 SETX SLF1 MAPT STXBP4 WRN MSH2 TEX15 TRIP12 CDC7 RAD51AP1 FANCB MSH6 KIN WDHD1 EGFR TNKS1BP1 BOD1L1 ATM USP1 SLX4 PML DYRK3	1.44e-05	959	183	23	GO:0006974
GeneOntologyBiologicalProcess	DNA recombination	RNF169 SETX SLF1 WRN MSH2 TEX15 CDC7 RAD51AP1 FANCB MSH6 KIN ATM SLX4	2.63e-05	368	183	13	GO:0006310
GeneOntologyBiologicalProcess	DNA metabolic process	RNF169 SETX SLF1 WRN MSH2 TEX15 TRIP12 DNAJC2 CDC7 MET RAD51AP1 FANCB MSH6 KIN WDHD1 EGFR TINF2 TNKS1BP1 BOD1L1 ATM OGA USP1 SLX4 PML	3.23e-05	1081	183	24	GO:0006259
GeneOntologyBiologicalProcess	double-strand break repair via homologous recombination	RNF169 SLF1 WRN TEX15 CDC7 RAD51AP1 FANCB ATM SLX4	4.77e-05	188	183	9	GO:0000724
GeneOntologyBiologicalProcess	recombinational repair	RNF169 SLF1 WRN TEX15 CDC7 RAD51AP1 FANCB ATM SLX4	6.09e-05	194	183	9	GO:0000725
GeneOntologyBiologicalProcess	establishment or maintenance of transmembrane electrochemical gradient	ATP1A1 ATP1A3 ATP12A	1.08e-04	11	183	3	GO:0010248
GeneOntologyBiologicalProcess	determination of adult lifespan	WRN MSH2 MSH6 ATM ATP1A3	1.16e-04	54	183	5	GO:0008340
GeneOntologyBiologicalProcess	intracellular sodium ion homeostasis	SCN7A ATP1A1 ATP1A3 ATP12A	1.37e-04	30	183	4	GO:0006883
GeneOntologyCellularComponent	chromosome, telomeric region	SETX SLF1 WRN MSH2 THOC3 RAD51AP1 TINF2 ATM SLX4 PML	3.75e-06	176	184	10	GO:0000781
GeneOntologyCellularComponent	MutSalpha complex	MSH2 MSH6	7.71e-05	2	184	2	GO:0032301
GeneOntologyCellularComponent	chromosomal region	SETX SLF1 CENPC AHCTF1 WRN MSH2 THOC3 RAD51AP1 WDHD1 TINF2 ATM SLX4 PML	9.58e-05	421	184	13	GO:0098687
GeneOntologyCellularComponent	photoreceptor inner segment membrane	ATP1A1 ATP1A3	4.57e-04	4	184	2	GO:0060342
Domain	-	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	1.35e-05	32	182	5	3.40.1110.10
Domain	-	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	1.35e-05	32	182	5	2.70.150.10
Domain	P-type_ATPase_IIC	ATP1A1 ATP1A3 ATP12A	1.78e-05	6	182	3	IPR005775
Domain	ATPase_P-typ_cation-transptr_C	ATP13A3 ATP1A1 ATP1A3 ATP12A	1.88e-05	17	182	4	IPR006068
Domain	Cation_ATPase_C	ATP13A3 ATP1A1 ATP1A3 ATP12A	1.88e-05	17	182	4	PF00689
Domain	ATPase_P-typ_cyto_domN	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	2.13e-05	35	182	5	IPR023299
Domain	Cation_ATPase_N	ATP13A3 ATP1A1 ATP1A3 ATP12A	2.40e-05	18	182	4	PF00690
Domain	ATPase_P-typ_P_site	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	2.45e-05	36	182	5	IPR018303
Domain	P_typ_ATPase	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	2.45e-05	36	182	5	IPR001757
Domain	ATPASE_E1_E2	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	2.45e-05	36	182	5	PS00154
Domain	ATPase_P-typ_transduc_dom_A	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	2.81e-05	37	182	5	IPR008250
Domain	E1-E2_ATPase	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	2.81e-05	37	182	5	PF00122
Domain	ATPase_P-typ_cation-transptr_N	ATP13A3 ATP1A1 ATP1A3 ATP12A	3.02e-05	19	182	4	IPR004014
Domain	-	TLN1 TLN2	9.44e-05	2	182	2	1.20.1420.10
Domain	-	RBPJL RBPJ	9.44e-05	2	182	2	2.60.40.1450
Domain	LAG1-DNAbind	RBPJL RBPJ	9.44e-05	2	182	2	PF09271
Domain	BTD	RBPJL RBPJ	9.44e-05	2	182	2	PF09270
Domain	VBS	TLN1 TLN2	9.44e-05	2	182	2	PF08913
Domain	Vinculin-bd_dom	TLN1 TLN2	9.44e-05	2	182	2	IPR015009
Domain	Talin_cent	TLN1 TLN2	9.44e-05	2	182	2	IPR015224
Domain	BTD	RBPJL RBPJ	9.44e-05	2	182	2	SM01268
Domain	LAG1_DNAbind	RBPJL RBPJ	9.44e-05	2	182	2	SM01267
Domain	Talin_middle	TLN1 TLN2	9.44e-05	2	182	2	PF09141
Domain	Beta-trefoil_DNA-bd_dom	RBPJL RBPJ	9.44e-05	2	182	2	IPR015350
Domain	LAG1_DNA-bd	RBPJL RBPJ	9.44e-05	2	182	2	IPR015351
Domain	TIG	RBPJL MET RBPJ CAMTA1	2.23e-04	31	182	4	PF01833
Domain	IPT	RBPJL MET RBPJ CAMTA1	2.53e-04	32	182	4	IPR002909
Domain	TAU_MAP_2	MAP4 MAPT	2.82e-04	3	182	2	PS51491
Domain	DUF2465	FAM98A FAM98B	2.82e-04	3	182	2	PF10239
Domain	Tubulin-binding	MAP4 MAPT	2.82e-04	3	182	2	PF00418
Domain	Uncharacterised_FAM98	FAM98A FAM98B	2.82e-04	3	182	2	IPR018797
Domain	MAP_tubulin-bd_rpt	MAP4 MAPT	2.82e-04	3	182	2	IPR001084
Domain	Talin-1	TLN1 TLN2	2.82e-04	3	182	2	IPR015710
Domain	TAU_MAP_1	MAP4 MAPT	2.82e-04	3	182	2	PS00229
Domain	DNA_mismatch_repair_MutS-lik_N	MSH2 MSH6	2.82e-04	3	182	2	IPR007695
Domain	MutS_I	MSH2 MSH6	2.82e-04	3	182	2	PF01624
Domain	MAP2/MAP4/Tau	MAP4 MAPT	2.82e-04	3	182	2	IPR027324
Domain	ATPase_P-typ_TM_dom	ATP1A1 ATP1A3 ATP12A	4.64e-04	16	182	3	IPR023298
Domain	-	ATP1A1 ATP1A3 ATP12A	4.64e-04	16	182	3	1.20.1110.10
Domain	ILWEQ_dom	TLN1 TLN2	5.59e-04	4	182	2	IPR002558
Domain	ILWEQ	TLN1 TLN2	5.59e-04	4	182	2	SM00307
Domain	FERM_f0	TLN1 TLN2	5.59e-04	4	182	2	PF16511
Domain	ILWEQ	TLN1 TLN2	5.59e-04	4	182	2	PD011820
Domain	DNA_mmatch_repair_MutS_con_dom	MSH2 MSH6	5.59e-04	4	182	2	IPR007860
Domain	-	TLN1 TLN2	5.59e-04	4	182	2	1.20.1410.10
Domain	I_LWEQ	TLN1 TLN2	5.59e-04	4	182	2	PF01608
Domain	I_LWEQ	TLN1 TLN2	5.59e-04	4	182	2	PS50945
Domain	MutS_II	MSH2 MSH6	5.59e-04	4	182	2	PF05188
Domain	FERM_f0	TLN1 TLN2	5.59e-04	4	182	2	IPR032425
Domain	Cation_ATPase_N	ATP1A1 ATP1A3 ATP12A	6.67e-04	18	182	3	SM00831
Domain	MUTSd	MSH2 MSH6	9.26e-04	5	182	2	SM00533
Domain	MUTSac	MSH2 MSH6	9.26e-04	5	182	2	SM00534
Domain	MutS_V	MSH2 MSH6	9.26e-04	5	182	2	PF00488
Domain	DNA_mismatch_repair_MutS_clamp	MSH2 MSH6	9.26e-04	5	182	2	IPR007861
Domain	DNA_MISMATCH_REPAIR_2	MSH2 MSH6	9.26e-04	5	182	2	PS00486
Domain	3'-5'_exonuclease_dom	EXD1 WRN	9.26e-04	5	182	2	IPR002562
Domain	35EXOc	EXD1 WRN	9.26e-04	5	182	2	SM00474
Domain	MutS_IV	MSH2 MSH6	9.26e-04	5	182	2	PF05190
Domain	MutS_III	MSH2 MSH6	9.26e-04	5	182	2	PF05192
Domain	TIF_beta_prop-like	THOC3 WDHD1	9.26e-04	5	182	2	IPR013979
Domain	DNA_mismatch_repair_MutS_C	MSH2 MSH6	9.26e-04	5	182	2	IPR000432
Domain	eIF2A	THOC3 WDHD1	9.26e-04	5	182	2	PF08662
Domain	DNA_pol_A_exo1	EXD1 WRN	9.26e-04	5	182	2	PF01612
Domain	DNA_mismatch_repair_MutS_core	MSH2 MSH6	9.26e-04	5	182	2	IPR007696
Domain	HAD-like_dom	ATP9A ATP13A3 ATP1A1 ATP1A3 ATP12A	1.05e-03	79	182	5	IPR023214
Domain	IQ	MYO9A MYO10 OBSCN SCN7A CAMTA1	1.17e-03	81	182	5	SM00015
Domain	Ig-like_fold	TMIGD1 DSCAM PSG5 RBPJL L1CAM OBSCN CMYA5 JAML PTPRT IGSF10 MET ICOS RBPJ BTN2A3P CAMTA1 USH2A	1.53e-03	706	182	16	IPR013783
Domain	JmjC	KDM3A KDM3B JARID2	1.58e-03	24	182	3	PF02373
Domain	tRNA-bd_arm	KIAA0408 SOX5 CEP152	1.58e-03	24	182	3	IPR010978
Domain	IQ_motif_EF-hand-BS	MYO9A MYO10 OBSCN SCN7A CAMTA1	1.87e-03	90	182	5	IPR000048
Domain	Vinculin/catenin	TLN1 TLN2	1.92e-03	7	182	2	IPR006077
Domain	-	TMIGD1 DSCAM PSG5 RBPJL L1CAM OBSCN CMYA5 JAML PTPRT IGSF10 MET ICOS RBPJ CAMTA1 USH2A	2.17e-03	663	182	15	2.60.40.10
Domain	FN3	DSCAM L1CAM OBSCN CMYA5 ELFN2 PTPRT USH2A	2.28e-03	185	182	7	SM00060
Domain	FN3	DSCAM L1CAM OBSCN CMYA5 ELFN2 PTPRT USH2A	3.42e-03	199	182	7	PS50853
Domain	Ig_V-set	DSCAM PSG5 OBSCN JAML IGSF10 ICOS BTN2A3P	3.42e-03	199	182	7	IPR013106
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	JCAD SHROOM3 AMER1 SETX MAP4 DOCK11 MYO9A MAPT KIAA0232 STXBP4 KDM3B FAM98A TRIP12 CEP350 ZNF106 MTMR4 PI4KA TNKS1BP1 BOD1L1 CEP152 SSH2 PEAK1 KIF13A CFAP97 PML	1.07e-11	861	189	25	36931259
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	JCAD RNF169 ANK3 CENPC ZFYVE16 RPAP3 STXBP4 TPTE2 TTC27 RNF213 MSH2 PTPRT CEP350 MSH6 MTMR4 EGFR CCNB2 PI4KA PEX19 SSH2 PEAK1 TRIM13 ZNF512 USP1	3.32e-09	1049	189	24	27880917
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	RNF169 ZFYVE16 RPAP3 MCC KDM3B RNF213 CHD1 NSDHL CEP350 NBAS ZNF106 MTMR4 KIN WDHD1 TTLL4 CIAPIN1 PEX19 BOD1L1 TRIM13 USP1	4.07e-09	733	189	20	34672954
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	MRPS31 TDRD15 SHROOM3 AMER1 SETX CAND1 ANK3 DSCAM WRN KDM3B RNF213 TRIP12 RYR2 CEP350 MET KIN EGFR PI4KA PEAK1 ATP1A1	1.08e-08	777	189	20	35844135
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KDM3A RNF169 SETX CENPC AHCTF1 WRN KDM3B CHD1 MSH2 THOC3 TRIP12 RAD51AP1 MSH6 RBPJ ZFP91 BOD1L1 ZNF512	4.45e-08	608	189	17	36089195
Pubmed	Genetic mutations associated with cigarette smoking in pancreatic cancer.	AMER1 MSH2 PTPRT MET MSH6 EGFR ATM	5.36e-08	63	189	7	19351817
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	AMER1 SETX ANK3 MAP4 STXBP4 AHCTF1 OBSCN DEPDC1 TRIP12 KIN WDHD1 PI4KA TTLL4 RBPJ BOD1L1 PEAK1 CAMTA1 KIF13A NLRP4 SLX4 PML ZNF445	1.28e-07	1084	189	22	11544199
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	MRPS31 SHROOM3 ANK3 CENPC RPAP3 STXBP4 AHCTF1 RTN3 CHD1 FAM98A PFKM TIMMDC1 DNAJC2 NSDHL MET NBAS EGFR PI4KA TLN1 PEX19 ATM PEAK1 TRIM13 ZNF512 OGA PML	1.58e-07	1487	189	26	33957083
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	RNF169 SETX SLF1 WRN FAM98B ARMCX2 FANCB ZNF106 DDX46 TINF2 BOD1L1 ATM SLX4 PML	2.17e-07	453	189	14	29656893
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	CENPC POGK STXBP4 AHCTF1 MCC TTC27 CEP350 NBAS FANCB ZNF106 DDX46 KIN CCNB2 TLN1 KLHL42 TLN2 KIF4B TNKS1BP1 CEP152 ATM SLX4 CFAP97	3.75e-07	1155	189	22	20360068
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	RNF169 WRN CHD1 MSH2 CDC7 MSH6 ZNF106 KIN SLX4 PML	4.27e-07	222	189	10	37071664
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SEC16B RNF169 CTTNBP2 ANKRD62 RNF213 ARMCX2 ELFN2 CEP350 CEP152 MINAR1 SSH2 PEAK1 ZNF512 SLX4	5.98e-07	493	189	14	15368895
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	CAND1 ZFYVE16 MAP4 RPAP3 STXBP4 AHCTF1 KDM3B CHD1 PFKM FABP5 MSH6 DDX46 TLN1 CIAPIN1 TNKS1BP1 BOD1L1 ATP1A1 OGA PML	9.39e-07	934	189	19	33916271
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KDM3A SEC16B RNF169 MAP4 MAPT KDM3B TRIP12 MSH6 ZNF106 DDX46 WDHD1 EGFR ZFP91 TLN2 TNKS1BP1 ATM OGA	1.29e-06	774	189	17	15302935
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KDM3A AGAP5 SHROOM3 SETX CAND1 KDM3B DDX46 CELSR3 TTLL4 MED12L KLHL42 TNKS1BP1 OGA CFAP97	1.37e-06	529	189	14	14621295
Pubmed	Multiple genes encode the human Na+,K+-ATPase catalytic subunit.	ATP1A1 ATP1A3 ATP12A	1.57e-06	5	189	3	3035563
Pubmed	Physical and functional interactions between Werner syndrome helicase and mismatch-repair initiation factors.	WRN MSH2 MSH6	1.57e-06	5	189	3	17715146
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MAP4 WRN MSH2 TRIP12 NBAS MSH6 EGFR PI4KA ATP1A1	1.79e-06	202	189	9	33005030
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	SETX CAND1 AHCTF1 CHD1 ARMCX2 TRIP12 JARID2 WDHD1 RBPJ TNKS1BP1 BOD1L1 UNC79 PML	1.99e-06	469	189	13	27634302
Pubmed	Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation.	MAP4 MYO9A RNF213 MSH2 PFKM CDC7 TLN1 TLN2 BOD1L1	2.27e-06	208	189	9	33230847
Pubmed	The family of human Na+,K+-ATPase genes. No less than five genes and/or pseudogenes related to the alpha-subunit.	ATP1A1 ATP1A3 ATP12A	3.12e-06	6	189	3	3036582
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RNF169 SETX SLF1 CENPC MAP4 AHCTF1 CHD1 FAM98A FAM98B THOC3 TRIP12 RAD51AP1 DDX46 TINF2 BOD1L1 ZNF512 SLX4 PML	5.22e-06	954	189	18	36373674
Pubmed	Proliferating cell nuclear antigen (PCNA)-binding protein C1orf124 is a regulator of translesion synthesis.	CAND1 MSH2 MSH6 SLX4	5.72e-06	22	189	4	22902628
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	KDM3A RNF169 SETX MAP4 PDSS1 RPAP3 KDM3B ZNF106 TLN1 TNKS1BP1 SLX4 PML	6.43e-06	444	189	12	34795231
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	AGAP5 SHROOM3 MYO10 L1CAM NAPA JARID2 TTLL4 RBPJ ZFP91 TLN2 CEP152 PEAK1 CAMTA1	8.42e-06	536	189	13	15840001
Pubmed	Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access.	EGFR ATM PML	8.67e-06	8	189	3	21704408
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	AGAP5 SHROOM3 MYO10 L1CAM NAPA JARID2 TTLL4 RBPJ ZFP91 TLN2 CEP152 PEAK1 CAMTA1	8.76e-06	538	189	13	10512203
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	MRPS31 ZFYVE16 MAPT STXBP4 AHCTF1 FAM98A THOC3 NSDHL RAD51AP1 KIN WDHD1 EGFR CCNB2 CIAPIN1 RBPJ PEX19 PEAK1 ATP1A1	1.08e-05	1007	189	18	34597346
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	KDM3A ANK3 MAP4 RPAP3 AHCTF1 KDM3B MSH6 DDX46 TLN1 CIAPIN1 TNKS1BP1 BOD1L1 PEAK1	1.09e-05	549	189	13	38280479
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	RNF169 CAND1 CENPC MAP4 KDM3B RNF213 CHD1 MSH2 FAM98B FABP5 MSH6 DDX46 WDHD1 CIAPIN1 ZFP91 BOD1L1 ATM PML	1.19e-05	1014	189	18	32416067
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MRPS31 CAND1 SLF1 CENPC MYO10 CHD1 THOC3 TIMMDC1 FAM186B NSDHL NBAS MSH6 ZNF106 DDX46 TP53TG5 TINF2 ATP13A3 SSH2 ATP1A3 OGA USP1	1.24e-05	1327	189	21	32694731
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	JCAD SHROOM3 ANK3 ZFYVE16 MAP4 ELFN2 EGFR CCNB2 PI4KA TLN1 CIAPIN1 TNKS1BP1 PEAK1	1.47e-05	565	189	13	25468996
Pubmed	Identification of different proteins binding to Na, K-ATPase α1 in LPS-induced ARDS cell model by proteomic analysis.	RNF213 MSH2 TRIP12 EGFR TLN1 ATP1A1 ATP1A3	1.47e-05	144	189	7	35681168
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	SHROOM3 SETX CAND1 MSH2 PFKM TRIP12 MSH6 DDX46 TLN1 MED12L TLN2 TNKS1BP1 ATM	2.00e-05	582	189	13	20467437
Pubmed	A Global Analysis of the Receptor Tyrosine Kinase-Protein Phosphatase Interactome.	SETX MAP4 SWT1 MYO9A TPTE2 PTPRT EYS EGFR ATP1A1 DYRK3 ZNF114	2.10e-05	420	189	11	28065597
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	SETX MYO9A STXBP4 RTN3 THOC3 CDC7 CCNB2 PI4KA RBPJ TNKS1BP1 ATP1A1 SLX4 PML	2.23e-05	588	189	13	38580884
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	CAND1 RPAP3 AHCTF1 TRIP12 MSH6 DDX46 ATP1A1	2.46e-05	156	189	7	37108203
Pubmed	SMC1 is a downstream effector in the ATM/NBS1 branch of the human S-phase checkpoint.	MSH2 MSH6 ATM	2.52e-05	11	189	3	11877377
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	JCAD SHROOM3 ANK3 MCC ANKRD62 FAM186B TRIP12 TLN1 SMIM34 ATM CAMTA1	2.60e-05	430	189	11	35044719
Pubmed	Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair.	CAND1 KDM3B FABP5 CEP350 DDX46 CIAPIN1 ZFP91 ATP1A1 SLX4 PML	2.84e-05	357	189	10	37059091
Pubmed	A putative Lynch syndrome family carrying MSH2 and MSH6 variants of uncertain significance-functional analysis reveals the pathogenic one.	MSH2 MSH6	2.94e-05	2	189	2	21431882
Pubmed	MET and EGFR mutations identified in ALK-rearranged pulmonary adenocarcinoma: molecular analysis of 25 ALK-positive cases.	MET EGFR	2.94e-05	2	189	2	23449277
Pubmed	The human mismatch recognition complex hMSH2-hMSH6 functions as a novel molecular switch.	MSH2 MSH6	2.94e-05	2	189	2	9428522
Pubmed	Highlights in NSCLC from the 2014 American Society of Clinical Oncology annual meeting.	MET EGFR	2.94e-05	2	189	2	25768032
Pubmed	The Association between EGFR and cMET Expression and Phosphorylation and Its Prognostic Implication in Patients with Breast Cancer.	MET EGFR	2.94e-05	2	189	2	27055285
Pubmed	Esophageal cancer risk is associated with polymorphisms of DNA repair genes MSH2 and WRN in Chinese population.	WRN MSH2	2.94e-05	2	189	2	22173703
Pubmed	Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activities.	MSH2 MSH6	2.94e-05	2	189	2	23391514
Pubmed	MET-EGFR dimerization in lung adenocarcinoma is dependent on EGFR mtations and altered by MET kinase inhibition.	MET EGFR	2.94e-05	2	189	2	28141869
Pubmed	Crizotinib sensitizes the erlotinib resistant HCC827GR5 cell line by influencing lysosomal function.	MET EGFR	2.94e-05	2	189	2	31960422
Pubmed	Multiplexed Exchange-PAINT imaging reveals ligand-dependent EGFR and Met interactions in the plasma membrane.	MET EGFR	2.94e-05	2	189	2	28939861
Pubmed	Mechanism of Resistance and Novel Targets Mediating Resistance to EGFR and c-Met Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.	MET EGFR	2.94e-05	2	189	2	26301867
Pubmed	Human DNA polymerase α interacts with mismatch repair proteins MSH2 and MSH6.	MSH2 MSH6	2.94e-05	2	189	2	27805738
Pubmed	Mechanism of c-Met and EGFR tyrosine kinase inhibitor resistance through epithelial mesenchymal transition in non-small cell lung cancer.	MET EGFR	2.94e-05	2	189	2	27396618
Pubmed	The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.	MSH2 MSH6	2.94e-05	2	189	2	22219001
Pubmed	Dual inhibition of EGFR and c-Met kinase activation by MJ-56 reduces metastasis of HT29 human colorectal cancer cells.	MET EGFR	2.94e-05	2	189	2	23677180
Pubmed	WRN is required for ATM activation and the S-phase checkpoint in response to interstrand cross-link-induced DNA double-strand breaks.	WRN ATM	2.94e-05	2	189	2	18596239
Pubmed	Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis.	MET EGFR	2.94e-05	2	189	2	20489150
Pubmed	Dual blockade of EGFR and c-Met abrogates redundant signaling and proliferation in head and neck carcinoma cells.	MET EGFR	2.94e-05	2	189	2	21622718
Pubmed	Met receptor acts uniquely for survival and morphogenesis of EGFR-dependent normal mammary epithelial and cancer cells.	MET EGFR	2.94e-05	2	189	2	23028720
Pubmed	Reduced Expression of Mismatch Repair Genes MSH6/MSH2 Directly Promotes Pituitary Tumor Growth via the ATR-Chk1 Pathway.	MSH2 MSH6	2.94e-05	2	189	2	29342268
Pubmed	Regulation of metastatic ability and drug resistance in pulmonary adenocarcinoma by matrix rigidity via activating c-Met and EGFR.	MET EGFR	2.94e-05	2	189	2	26000960
Pubmed	Clinicopathologic and molecular features of epidermal growth factor receptor T790M mutation and c-MET amplification in tyrosine kinase inhibitor-resistant Chinese non-small cell lung cancer.	MET EGFR	2.94e-05	2	189	2	19381876
Pubmed	Properties and expression of Na+/K+-ATPase α-subunit isoforms in the brain of the swamp eel, Monopterus albus, which has unusually high brain ammonia tolerance.	ATP1A1 ATP1A3	2.94e-05	2	189	2	24391932
Pubmed	Ability of the Met kinase inhibitor crizotinib and new generation EGFR inhibitors to overcome resistance to EGFR inhibitors.	MET EGFR	2.94e-05	2	189	2	24386407
Pubmed	Signaling networks assembled by oncogenic EGFR and c-Met.	MET EGFR	2.94e-05	2	189	2	18180459
Pubmed	Na+/K+ ATPase α1 and α3 isoforms are differentially expressed in α- and γ-motoneurons.	ATP1A1 ATP1A3	2.94e-05	2	189	2	23761886
Pubmed	The Role of EGFR-Met Interactions in the Pathogenesis of Glioblastoma and Resistance to Treatment.	MET EGFR	2.94e-05	2	189	2	28004613
Pubmed	HMSH2 and HMSH6 gene expression profiles in colorectal adenocarcinoma in patients up to 50 years of age.	MSH2 MSH6	2.94e-05	2	189	2	27459116
Pubmed	Human MSH2 (hMSH2) protein controls ATP processing by hMSH2-hMSH6.	MSH2 MSH6	2.94e-05	2	189	2	21937421
Pubmed	Status of mismatch repair genes hMSH2 and hMSH6 in colorectal cancer in Saudi patients: an immunohistochemical analysis.	MSH2 MSH6	2.94e-05	2	189	2	23301373
Pubmed	Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment.	MET EGFR	2.94e-05	2	189	2	27450722
Pubmed	MutSalpha binds to and promotes synapsis of transcriptionally activated immunoglobulin switch regions.	MSH2 MSH6	2.94e-05	2	189	2	15753043
Pubmed	The family of human Na+,K+-ATPase genes. A partial nucleotide sequence related to the alpha-subunit.	ATP1A1 ATP1A3	2.94e-05	2	189	2	3030810
Pubmed	MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a de novo phenomenon.	MET EGFR	2.94e-05	2	189	2	27421137
Pubmed	Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation.	CHIA EGFR	2.94e-05	2	189	2	30644388
Pubmed	EGFR wild type antagonizes EGFRvIII-mediated activation of Met in glioblastoma.	MET EGFR	2.94e-05	2	189	2	24362532
Pubmed	Nucleosome remodeling by hMSH2-hMSH6.	MSH2 MSH6	2.94e-05	2	189	2	20064472
Pubmed	Structure of the human MutSalpha DNA lesion recognition complex.	MSH2 MSH6	2.94e-05	2	189	2	17531815
Pubmed	Expression and role of acidic mammalian chitinase and eotaxin-3 in chronic rhinosinusitis with nasal polyps.	CHIA CCL26	2.94e-05	2	189	2	21303604
Pubmed	Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma.	MET EGFR	2.94e-05	2	189	2	26810066
Pubmed	Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.	TLN1 TLN2	2.94e-05	2	189	2	26822056
Pubmed	Immunohistochemical analyses of alpha1 and alpha3 Na+/K+-ATPase subunit expression in medulloblastomas.	ATP1A1 ATP1A3	2.94e-05	2	189	2	21498719
Pubmed	Extracellular rigidity sensing by talin isoform-specific mechanical linkages.	TLN1 TLN2	2.94e-05	2	189	2	26523364
Pubmed	Deciphering the mismatch recognition cycle in MutS and MSH2-MSH6 using normal-mode analysis.	MSH2 MSH6	2.94e-05	2	189	2	19254532
Pubmed	Specific fate decisions in adult hepatic progenitor cells driven by MET and EGFR signaling.	MET EGFR	2.94e-05	2	189	2	23913923
Pubmed	Degadration of mismatch repair hMutSalpha heterodimer by the ubiquitin-proteasome pathway.	MSH2 MSH6	2.94e-05	2	189	2	15043999
Pubmed	Mismatch repair protein hMSH2-hMSH6 recognizes mismatches and forms sliding clamps within a D-loop recombination intermediate.	MSH2 MSH6	2.94e-05	2	189	2	24395779
Pubmed	Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients.	MET EGFR	2.94e-05	2	189	2	25453846
Pubmed	Biochemical analysis of the human mismatch repair proteins hMutSα MSH2(G674A)-MSH6 and MSH2-MSH6(T1219D).	MSH2 MSH6	2.94e-05	2	189	2	22277660
Pubmed	MSH2 118T>C and MSH6 159C>T promoter polymorphisms and the risk of colorectal cancer.	MSH2 MSH6	2.94e-05	2	189	2	17942459
Pubmed	MET FISH-positive status predicts short progression-free survival and overall survival after gefitinib treatment in lung adenocarcinoma with EGFR mutation.	MET EGFR	2.94e-05	2	189	2	25886066
Pubmed	The Tendency of Having MSH2 and MSH6 Microsatellite Instability among Clinicopathological Features in Patients with Colorectal Cancer.	MSH2 MSH6	2.94e-05	2	189	2	30486602
Pubmed	Co-expression of EGFR and MET has a synergistic effect on the prognosis of patients with oral squamous cell carcinoma.	MET EGFR	2.94e-05	2	189	2	31762177
Pubmed	Loss of hepatocyte EGFR has no effect alone but exacerbates carbon tetrachloride-induced liver injury and impairs regeneration in hepatocyte Met-deficient mice.	MET EGFR	2.94e-05	2	189	2	25414100
Pubmed	Cross-talk between epidermal growth factor receptor and c-Met signal pathways in transformed cells.	MET EGFR	2.94e-05	2	189	2	10722725
Pubmed	Conformational change in MSH2-MSH6 upon binding DNA coupled to ATPase activity.	MSH2 MSH6	2.94e-05	2	189	2	19486659
Pubmed	Expression of receptor tyrosine kinases in esophageal carcinosarcoma.	MET EGFR	2.94e-05	2	189	2	23546020
Pubmed	Characterization of In Vivo Resistance to Osimertinib and JNJ-61186372, an EGFR/Met Bispecific Antibody, Reveals Unique and Consensus Mechanisms of Resistance.	MET EGFR	2.94e-05	2	189	2	28830985
Pubmed	Assessing the role of MSH2 and MSH6 gene expression deficiency in prostate cancer progression, a cross-sectional study.	MSH2 MSH6	2.94e-05	2	189	2	38870667
Pubmed	[Detection of epidermal growth factor receptor and c-Met gene copies for prognostic evaluation of non-small cell lung cancer].	MET EGFR	2.94e-05	2	189	2	21354913
Interaction	SLX4 interactions	RNF169 CAND1 WRN KDM3B CHD1 MSH2 FABP5 CDC7 CEP350 MSH6 ZNF106 DDX46 KIN CIAPIN1 ZFP91 ATP1A1 SLX4 PML	4.61e-06	572	182	18	int:SLX4
Cytoband	3p21.32	ZNF35 ZNF445	1.67e-04	5	189	2	3p21.32
GeneFamily	Fibronectin type III domain containing	DSCAM L1CAM OBSCN CMYA5 ELFN2 PTPRT USH2A	1.12e-04	160	123	7	555
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF880 ZNF619 ZNF248 ZNF71 ZNF106 ZIK1 ZNF35 ZNF732 ZFP91 ZNF512 ZNF454 ZNF730 ZNF114 ZNF445	3.77e-04	718	123	14	28
GeneFamily	MutS homologs\|PWWP domain containing	MSH2 MSH6	4.53e-04	5	123	2	1026
GeneFamily	ATPase Na+/K+ transporting subunits	ATP1A1 ATP1A3	9.43e-04	7	123	2	1208
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	CENPC DOCK11 MYO10 WRN CEP350 ZNF106 TTLL4 TLN1 MED12L ATP13A3 ATM	7.52e-08	180	187	11	M8239
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	KDM3A SETX CAND1 CENPC ZFYVE16 MYO10 AHCTF1 WRN KDM3B CHD1 MSH2 TRIP12 DNAJC2 CEP350 JARID2 NBAS MSH6 KIN WDHD1 EGFR RBPJ ATP13A3	2.26e-07	856	187	22	M4500
Coexpression	HAMAI_APOPTOSIS_VIA_TRAIL_UP	MRPS31 SETX CTTNBP2 SLF1 CENPC RPAP3 MYO9A MYO10 AHCTF1 WRN CHD1 DEPDC1 MSH2 CEP350 RAD51AP1 DDX46 WDHD1 ATM USP1	2.67e-07	656	187	19	M18979
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	CENPC KIAA0232 CHD1 CEP350 JARID2 WDHD1 CCNB2 RBPJ ATP13A3 TRIM13 USP1	1.12e-05	300	187	11	M8702
Coexpression	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	TRIP12 FABP5 CDC7 TINF2 CIBAR1 ZFP91 PEX19 CEP152 USP1	1.44e-05	200	187	9	M6544
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3	SOX5 SETX SLF1 CENPC PDSS1 SWT1 MYO10 STXBP4 AHCTF1 CHD1 DEPDC1 FAM98B DNAJC2 CEP350 JARID2 RAD51AP1 MSH6 CCDC66 DDX46 ZIK1 KIN CIBAR1 BOD1L1 ATM USP1 ZNF454 CFAP97 DYRK3	1.84e-06	1257	177	28	facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlas	FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3	SETX CENPC PDSS1 RPAP3 DOCK11 AHCTF1 CHD1 FAM98A FAM98B DNAJC2 RAD51AP1 MSH6 ZNF106 DDX46 ATM USP1	1.04e-05	532	177	16	Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500_K1	SOX5 IL15RA SETX SLF1 ANK3 CENPC PDSS1 SWT1 STXBP4 AHCTF1 DEPDC1 FAM98B DNAJC2 FABP5 CDC7 IGSF10 JARID2 RAD51AP1 MSH6 CCDC66 DDX46 ZIK1 KIN BOD1L1 USP1 ZNF454	1.33e-05	1241	177	26	facebase_RNAseq_e10.5_MandArch_2500_K1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	SETX ANK3 MYO10 WRN CHD1 TRIP12 ZNF248 CEP350 RBPJ TLN2 MIGA1 ATP13A3 OGA	1.41e-05	369	177	13	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_LatNas_2500	SOX5 SETX SLF1 CENPC PDSS1 SWT1 MYO10 STXBP4 AHCTF1 CHD1 DEPDC1 FAM98B DNAJC2 CEP350 JARID2 RAD51AP1 MSH6 CCDC66 DDX46 ZIK1 KIN CIBAR1 BOD1L1 ATM USP1 ZNF454 CFAP97 DYRK3	2.96e-05	1459	177	28	facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_MandArch_2500	SOX5 IL15RA SETX SLF1 ANK3 CENPC PDSS1 SWT1 STXBP4 AHCTF1 DEPDC1 FAM98B KRT80 DNAJC2 FABP5 CDC7 IGSF10 JARID2 RAD51AP1 MSH6 C9orf152 CCDC66 DDX46 ZIK1 KIN BOD1L1 USP1 ZNF454	3.30e-05	1468	177	28	facebase_RNAseq_e10.5_MandArch_2500
CoexpressionAtlas	facebase_RNAseq_e10.5_MaxArch_2500_K3	SOX5 SETX CENPC PDSS1 SWT1 STXBP4 AHCTF1 CHD1 DEPDC1 FAM98B KRT80 DNAJC2 IGSF10 JARID2 RAD51AP1 CCDC66 DDX46 ZIK1 KIN CCNB2 BOD1L1 ATM USP1 ZNF454 CFAP97	4.39e-05	1252	177	25	facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlas	dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_1000	SETX SWT1 EXD1 RPAP3 TTC27 RNF213 MSH2 TEX15 CDC7 JARID2 FANCB MSH6 WDHD1 ZDHHC23 CCNB2 MED12L ATM TRIM13 NLRP4	5.94e-05	822	177	19	gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_1000
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000	SOX5 AMER1 MAP4 EXD1 DOCK11 MYO9A RNF213 TEX15 THSD7B RYR2 ENO4 C9orf152 CIBAR1 PEAK1 CAMTA1 TCFL5 CFAP97 ZNF445	1.21e-04	795	177	18	gudmap_developingGonad_e16.5_ovary_1000
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000	SOX5 MAP4 RNF213 TEX15 THSD7B RYR2 ENO4 PEAK1 CFAP97	1.39e-04	230	177	9	gudmap_developingGonad_e18.5_ovary_1000_k5
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000	SETX SWT1 EXD1 RPAP3 MYO9A TTC27 RNF213 MSH2 TEX15 CDC7 FANCB WDHD1 ZDHHC23 CCNB2 ATM TRIM13 NLRP4 TCFL5	1.53e-04	810	177	18	gudmap_dev gonad_e13.5_M_GermCell_Oct_1000
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000	SETX SWT1 EXD1 MYO9A TTC27 MSH2 TEX15 CDC7 FANCB WDHD1 ZDHHC23 CCNB2 RNF141 MED12L ATM SSH2 NLRP4 TCFL5	1.78e-04	820	177	18	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	SOX5 SETX SLF1 CENPC SWT1 STXBP4 CHD1 DEPDC1 FAM98B KRT80 RAD51AP1 CCDC66 DDX46 ZIK1 TTLL4 BOD1L1 ATM CAMTA1 USP1 ZNF454 HDC	2.10e-04	1060	177	21	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SLF1 DEPDC1 RAD51AP1 FANCB WDHD1 CCNB2 CEP152 USP1 ZNF730	1.23e-07	191	187	9	50854384fdaa0efa2e3227659d544ed09ac102f2
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	CTTNBP2 ANK3 MAPT L1CAM NAPA PFKM ATP9A ATP1A3 UNC79	1.81e-07	200	187	9	09fd3cb31bcc02444f1045f01fe39bce09359d35
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	SLF1 RAD51AP1 FANCB WDHD1 ZNF732 CEP152 USP1 ZNF730	1.77e-06	195	187	8	56d8734d020b3da08a5aa9e67999706a9e023a99
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	SLF1 CDC7 RAD51AP1 FANCB WDHD1 ZNF732 CEP152 ZNF730	1.84e-06	196	187	8	df366d76ea55f49e349d622effa57c1535df8400
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	OR8H1 TEX15 THSD7B ADGRG4 PTPRT EYS USH2A	2.06e-06	139	187	7	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	CTTNBP2 ANK3 MAPT L1CAM PFKM ATP9A ATP1A3 UNC79	2.14e-06	200	187	8	e9eb348a66011d8aace4331f84690ae27cb0d061
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SETX CENPC RNF213 CHD1 TRIP12 CEP350 BOD1L1 ATM	2.14e-06	200	187	8	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A RBPJL RYR2 CCNB2 HSD17B13 ATP12A LYPD8	5.44e-06	161	187	7	b9a17f41426bf715f30bf544a6795afaf37a3aa6
ToppCell	facs-Pancreas-Exocrine-24m-Epithelial-pancreatic_acinar_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A RBPJL RYR2 CCNB2 HSD17B13 ATP12A LYPD8	5.44e-06	161	187	7	f7a89c481f789f624102857be722c95fbeb47595
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	JCAD OBSCN THSD7B CMYA5 KRT80 ZDHHC23 PEAK1	5.67e-06	162	187	7	58da6bc04cdac0002b0e6a751c96ff95e1a7f70f
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	DSCAM RBPJL THSD7B PTPRT RYR2 EYS USH2A	5.90e-06	163	187	7	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DEPDC1 TEX15 CDC7 RAD51AP1 WDHD1 ZNF732 ZNF730	7.48e-06	169	187	7	121768fc51fc3441ec725346a1bbe29e21d05971
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM PTPRT RYR2 ATP12A USH2A KLKB1 UNC79	7.48e-06	169	187	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHIA ANK3 RBPJL TEX15 FABP5 MET USP1	7.78e-06	170	187	7	4ce81608111b9ee7cb974dad2c182f38db3dcd79
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	TMIGD1 RPAP3 DEPDC1 CDC7 RAD51AP1 FANCB WDHD1	1.26e-05	183	187	7	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 DOCK11 MYO9A PTPRT MET EGFR FBXL2	1.50e-05	188	187	7	63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68
ToppCell	renal_cortex_nuclei-Adult_normal_reference\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 ANK3 MYO10 SH3BP2 EGFR BOD1L1 ATP1A1	1.55e-05	189	187	7	a48df46274d51e84ffb40264646de7346104efb9
ToppCell	droplet-Spleen-nan-24m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EMILIN2 DEPDC1 PFKM RAD51AP1 CCNB2 IFRD2 DYRK3	1.60e-05	190	187	7	a273fc119baebc11020009c923beafeebb6428c9
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAM TEX15 THSD7B PTPRT EYS USH2A	1.69e-05	128	187	6	91072ca56bce2c552a95edd67e17f43d8cc1de95
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DSCAM MAPT L1CAM RTN3 JARID2 CELSR3 ATP1A3	1.71e-05	192	187	7	d8f5df2c2a50e567f24ebecc8033ac97ba89d9c5
ToppCell	3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DSCAM MAPT L1CAM RTN3 JARID2 CELSR3 ATP1A3	1.77e-05	193	187	7	9661ea0ee7273928c7de2a9f49e853595fa77699
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DEPDC1 RAD51AP1 FANCB WDHD1 ZNF732 CEP152 ZNF730	1.83e-05	194	187	7	590a9d4f054e6a3685daf752c9354650fcc7d18a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	SLF1 CDC7 RAD51AP1 FANCB WDHD1 CEP152 ZNF730	1.89e-05	195	187	7	cec7df321f372d05c94f97d6bb18891a5cc3dec3
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	RAD51AP1 FANCB WDHD1 ZNF732 CEP152 USP1 ZNF730	1.89e-05	195	187	7	b65463a804fed2d9a3be9e528ca8b9c98469bc86
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_cycling\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	DEPDC1 RAD51AP1 FANCB WDHD1 CCNB2 CEP152 ZNF730	1.96e-05	196	187	7	1d2e0b328eb822db7521b5f5724d4bd17c0bad5f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AMER1 PSG5 L1CAM NSDHL CELSR3 USH2A UNC79	1.96e-05	196	187	7	4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPC DEPDC1 CDC7 RAD51AP1 CCNB2 SCN7A USP1	1.96e-05	196	187	7	0644bd14a944b9c9759a295dfdd5e67a4775f20a
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_cycling\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	DEPDC1 RAD51AP1 FANCB WDHD1 CCNB2 CEP152 ZNF730	2.02e-05	197	187	7	8b616cde333bdbc0c591035ad9e4949155866245
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	ANKRD62 DNAJC2 CEP350 DDX46 BOD1L1 CEP152 OGA	2.02e-05	197	187	7	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	SOX5 SHROOM3 ANK3 MYO9A EGFR PEAK1 KIF13A	2.09e-05	198	187	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	DEPDC1 MSH2 CDC7 RAD51AP1 FANCB WDHD1 ZDHHC23	2.16e-05	199	187	7	1d5a3366474c17e3df0ba5cf11b586655529e9bd
ToppCell	severe-T/NK_proliferative\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DEPDC1 MSH2 FABP5 RAD51AP1 MSH6 WDHD1 CCNB2	2.23e-05	200	187	7	9d6e7e2d6cfa8c96bbb5c187815df96ecaa5475c
ToppCell	356C-Lymphocytic-NK_cells-Proliferating_NK_cell\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	DEPDC1 FABP5 RAD51AP1 MSH6 WDHD1 CCNB2 USP1	2.23e-05	200	187	7	97e47eb69d1d4cab45256acca9589837eb7817e7
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW13-Mesenchymal-Mesoderm\|GW13 / Sample Type, Dataset, Time_group, and Cell type.	POGK MCC CMYA5 ZNF71 KLHL42 MINAR1 ZNF454	2.23e-05	200	187	7	0f4b8b0868bda406fe6bf01d1b722510fdfd0168
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal-Neurons\|GW09 / Sample Type, Dataset, Time_group, and Cell type.	CTTNBP2 MAPT L1CAM PFKM ATP9A ATP1A3 UNC79	2.23e-05	200	187	7	ddac952ad1d46021c2d17d816de9bc31730a0941
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MSH2 CDC7 RAD51AP1 MSH6 WDHD1 CCNB2 USP1	2.23e-05	200	187	7	7e4c0db43a03ca11380a54f44a3cf1991e055b80
ToppCell	COVID_vent-Lymphocytic-Proliferative_Lymphocyte\|COVID_vent / Disease condition, Lineage, Cell class and subclass	MSH2 CDC7 RAD51AP1 MSH6 WDHD1 CCNB2 USP1	2.23e-05	200	187	7	9775ca7dedb76fcbb74f80f86b33c94e394c320a
ToppCell	mild-T/NK_proliferative\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	DEPDC1 MSH2 CDC7 RAD51AP1 WDHD1 CCNB2 CEP152	2.23e-05	200	187	7	63cc57b9331459efbb73051d174d198a3568b938
ToppCell	COVID-19-kidney-Technical/muscle_(PCT)\|kidney / Disease (COVID-19 only), tissue and cell type	DSCAM THSD7B PTPRT RYR2 EYS USH2A	3.56e-05	146	187	6	c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAM THSD7B PTPRT CACNG2 EYS USH2A	3.84e-05	148	187	6	d6ac5972267254651dfbe16bb4e9a62228093cc7
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DSCAM RBPJL THSD7B PTPRT EYS USH2A	4.14e-05	150	187	6	0205318a870e091add66ee4305747dda9f51510d
ToppCell	COVID-19_Mild\|World / 5 Neutrophil clusters in COVID-19 patients	SOX5 ANK3 MAPT JAML C4orf36 OGA	4.46e-05	152	187	6	2ff0980dfd8d430cca14649151d856edef115720
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	ANK3 CENPC RNF213 CHD1 KIF4B ATM	5.16e-05	156	187	6	1545169694f686d28648a68b552c2ae606599d66
ToppCell	frontal_cortex-Neuronal-glutamatergic_neuron-L5_IT-L5_IT_ALM_Lypd1_Gpr88\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SEC16B SHROOM3 JAML MET SCN7A HSD17B13	5.34e-05	157	187	6	5aee90ad7aaa65fdabc23597451da5e48db8f4e6
ToppCell	TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-2\|TCGA-Lung / Sample_Type by Project: Shred V9	RTN3 MSH2 CDC7 WDHD1 USP1 ZNF730	5.53e-05	158	187	6	9dea15b28f64206bac0e785df6f36a2cc9010ac7
ToppCell	COVID-19-kidney-Technical/muscle_(Mes)\|kidney / Disease (COVID-19 only), tissue and cell type	DSCAM THSD7B PTPRT RYR2 EYS USH2A	5.73e-05	159	187	6	5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCell	facs-Heart-RV-24m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM DEPDC1 CACNG2 C9orf152 C17orf78 HDC	5.93e-05	160	187	6	41d6c811c445c0ba9b6a2deb10a3b6b793172582
ToppCell	facs-Heart-RV-24m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DSCAM DEPDC1 CACNG2 C9orf152 C17orf78 HDC	5.93e-05	160	187	6	c1d03c0ac9c12615a06499209fcdf18e9b6f1fba
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Sla\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	JCAD OBSCN THSD7B CMYA5 ZDHHC23 PEAK1	6.36e-05	162	187	6	4d13c271b4f63cf32980e5643b5d5951165fe8b5
ToppCell	Basal_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	MCC ANKRD62 MET HSD17B13 ATP1A3 ATP12A	6.58e-05	163	187	6	679e25e5548d157d49a73057a3b5617dccda260f
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_VISp_Ctxn3_Brinp3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	JCAD OBSCN THSD7B CMYA5 KRT80 PEAK1	6.58e-05	163	187	6	b0aa4a620bd58011225b42ea6dda04e3101ba342
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DSCAM EXD1 MAPT PTPRT CACNG2 EYS	7.52e-05	167	187	6	3edb0570e583bb527165bcd8a4c25a042054043b
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MSH2 RAD51AP1 MSH6 WDHD1 CCNB2 USP1	7.52e-05	167	187	6	3461d14e36f09ddc6ee5549ca4797e16d3f37fcc
ToppCell	facs-Marrow-T-cells-3m-Myeloid-promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM EMILIN2 KRT80 MET MTMR4 ATP1A3	8.30e-05	170	187	6	a78d9789c3e7c84a36e1bd380192d7aba4a4d443
ToppCell	facs-Marrow-T-cells-3m-Myeloid-monocyte_+_promonocyte\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM EMILIN2 KRT80 MET MTMR4 ATP1A3	8.30e-05	170	187	6	ff68600b945b3a5437b14e5411b3db800d0ccbe5
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DEPDC1 RAD51AP1 WDHD1 SCN7A NOSTRIN USP1	9.43e-05	174	187	6	66555c610251ea04f968c258e312d720c18e7cde
ToppCell	Healthy_Control-Myeloid-Mast\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	CTTNBP2 MYO10 OBSCN SCN7A TNKS1BP1 HDC	9.73e-05	175	187	6	ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf
ToppCell	Healthy_Control-Myeloid-Mast-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	CTTNBP2 MYO10 OBSCN SCN7A TNKS1BP1 HDC	9.73e-05	175	187	6	eadbbcdf2aef4cee268bc70a7a2c4175d898953b
ToppCell	390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	SLF1 ANK3 JAML CCDC66 ZDHHC23 RBPJ	9.73e-05	175	187	6	6374ab186d7ccf7f6dfb858267edba8962789e15
ToppCell	facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CMYA5 JAML EGFR MED12L ATP1A1	1.00e-04	176	187	6	74f851a398c7562dd713bc0d8d488c0037243112
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DEPDC1 JAML CDC7 RAD51AP1 CCNB2 MED12L	1.00e-04	176	187	6	581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO9A CMYA5 RYR2 CEP350 IGSF10 ZNF106	1.00e-04	176	187	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	facs-Marrow-T_cells-18m-Myeloid-macrophage\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	OBSCN CMYA5 JAML EGFR MED12L ATP1A1	1.00e-04	176	187	6	31b5459a978d5cdde0af03a77401e0464d8c95ba
ToppCell	RV-11._Adipocyte\|World / Chamber and Cluster_Paper	SOX5 DOCK11 RTN3 ATP9A TLN2 OGA	1.04e-04	177	187	6	f0edf04930692418953e4f00a917257804ec0ffd
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CTTNBP2 DOCK11 MYO9A PTPRT EGFR SLX4	1.07e-04	178	187	6	c20f050344a2e120e685e2a7fe36c6dfc1dc37b6
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CENPC DEPDC1 CDC7 WDHD1 CCNB2 TTLL4	1.14e-04	180	187	6	5e1680088065be14447d5d5465f91f7edd071a1e
ToppCell	control-Lymphoid-NKT-proliferating\|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DEPDC1 FAM186B FABP5 RAD51AP1 FANCB CCNB2	1.14e-04	180	187	6	535535a67b3f3320bad2f98b1bc98a7b0ee77840
ToppCell	Control-Myeloid-Dendritic_cells\|Control / group, cell type (main and fine annotations)	EMILIN2 RAPGEF1 JAML JARID2 RBPJ MED12L	1.14e-04	180	187	6	25ad95c3c30e3b82abe93bd77ba003f5c2241f7c
ToppCell	facs-Marrow-T-cells-3m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	L1CAM EMILIN2 MET ATP13A3 ATP1A1 ATP1A3	1.17e-04	181	187	6	7286700396676fdc41d9723979b8b408177aceb9
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EXD1 DEPDC1 ELFN2 RAD51AP1 CCNB2 SLX4	1.21e-04	182	187	6	39f9b3eb22293cc27c6e175702c77d1eeb24fdc9
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T\|Liver / Manually curated celltypes from each tissue	ANKRD62 DEPDC1 RAD51AP1 WDHD1 CCNB2 KIF4B	1.21e-04	182	187	6	81557cdc88777f3bd4e1dd18a760b08fc29122ef
ToppCell	NS-control-d_0-4-Lymphoid-NKT-proliferating\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DEPDC1 FAM186B FABP5 RAD51AP1 FANCB CCNB2	1.21e-04	182	187	6	f623c47e7806181d09f126066a952162ce49a306
ToppCell	Control-T/NK_proliferative\|Control / Disease group and Cell class	DEPDC1 ATP9A ENO4 RAD51AP1 CCNB2 NOSTRIN	1.24e-04	183	187	6	09c2b4e630f1c338f02c1242e3598e870d6b0a28
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 OBSCN RYR2 TLN2 USH2A UNC79	1.28e-04	184	187	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 OBSCN RYR2 TLN2 USH2A UNC79	1.28e-04	184	187	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KIAA0408 OBSCN RYR2 TLN2 USH2A UNC79	1.28e-04	184	187	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHIA ANK3 RBPJL TEX15 FABP5 HDC	1.32e-04	185	187	6	2adb32096aa3473f8d417e5ce9e65264beca9b52
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SOX5 ANK3 RTN3 TLN2 SSH2 ATP12A	1.32e-04	185	187	6	d602a9b35e86e6f2a14a58e40fc4fb97f5fa3b08
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L3-4_RORB_RPS3P6\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	RBPJL ANKRD62 CMYA5 SCN7A CEP152 USH2A	1.32e-04	185	187	6	10da5c2a92bfb3248d3f6f94a0933996326cf590
ToppCell	Substantia_nigra-Neuronal-Inhibitory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	L1CAM CACNG2 CELSR3 CAMTA1 ATP1A3 UNC79	1.36e-04	186	187	6	9d3efe2a4feea2bc205a7e45b9b9f9ed9b3609ce
ToppCell	Substantia_nigra-Neuronal\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	L1CAM CACNG2 CELSR3 CAMTA1 ATP1A3 UNC79	1.36e-04	186	187	6	3f889083fcffe516388e9b03a5e23af2010ced33
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SOX5 MYO10 STXBP4 OBSCN ANKRD62 RYR2	1.40e-04	187	187	6	86250acf088ec0c4800a0dfa031b0d4f7e52c342
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 FAM98B ZDHHC23 TTLL4 ZNF512 KIF13A	1.40e-04	187	187	6	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRPS31 ANK3 MYO9A RYR2 TTLL4 KIF13A	1.44e-04	188	187	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRPS31 ANK3 MYO9A RYR2 TTLL4 KIF13A	1.44e-04	188	187	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MRPS31 ANK3 MYO9A RYR2 TTLL4 KIF13A	1.44e-04	188	187	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	WRN DEPDC1 TEX15 BTN2A3P KIF4B CEP152	1.44e-04	188	187	6	0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SOX5 MYO10 STXBP4 OBSCN ANKRD62 RYR2	1.44e-04	188	187	6	ee151792c7ac9afe820f1a281c6dab383799f358
ToppCell	3'_v3-lymph-node_spleen-Myeloid_Dendritic-Cycling_Dendritic\|lymph-node_spleen / Manually curated celltypes from each tissue	DEPDC1 TEX15 FABP5 RAD51AP1 CCNB2 ZNF114	1.44e-04	188	187	6	723348a1836a074e068320cb736ce6a953e0038f
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHIA ANK3 RBPJL TEX15 FABP5 MET	1.44e-04	188	187	6	7499e353ea5853d06558b20cedee3c7910425d7d
ToppCell	PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHIA ANK3 RBPJL TEX15 FABP5 MET	1.44e-04	188	187	6	562f5984efdbbcb8f53ddcee033ccbf9eb678425
ToppCell	Control-Myeloid-Monocytes\|Control / group, cell type (main and fine annotations)	SH3BP2 EMILIN2 JAML TG JARID2 SSH2	1.48e-04	189	187	6	3335d16bd0ffa0c1ddd06d7da645299148130c3f
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	SOX5 MAPT MYO10 OBSCN ANKRD62 RYR2	1.48e-04	189	187	6	d7ed96add29f219183c802895fbff519b627f635
ToppCell	PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHIA ANK3 RBPJL TEX15 FABP5 MET	1.52e-04	190	187	6	8ff8c586237cf15f930416710bcff45205fe6f70
ToppCell	PND14-Epithelial\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CHIA ANK3 RBPJL FABP5 MET HDC	1.52e-04	190	187	6	f1eeef8f201bf7b96c020c8ab53dd7e05b3060ea
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SOX5 MYO10 STXBP4 OBSCN ANKRD62 RYR2	1.52e-04	190	187	6	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	Globus_pallidus-Neuronal\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	L1CAM RYR2 CACNG2 CELSR3 CAMTA1 ATP1A3	1.52e-04	190	187	6	416de85d8841dac883faa6f5339b2fb461a09e82
ToppCell	PBMC-Severe-cDC_12\|Severe / Compartment, Disease Groups and Clusters	SLF1 MSH2 RAD51AP1 MSH6 WDHD1 ZNF730	1.52e-04	190	187	6	84ee185939bdefb10705b621a70da27701eadcee
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	ANK3 MAPT RYR2 IGSF10 ATP1A1 ATP1A3	1.52e-04	190	187	6	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SOX5 MYO10 STXBP4 OBSCN ANKRD62 RYR2	1.52e-04	190	187	6	7be4341e2909101d756f14031c21e705eb45e69a
Disease	alcohol use disorder (implicated_via_orthology)	KDM3A KDM3B RYR2 EGFR RBPJ SSH2 ATP1A1 ATP1A3 UNC79	3.22e-06	195	179	9	DOID:1574 (implicated_via_orthology)
Disease	epilepsy (implicated_via_orthology)	MAPT L1CAM KCNA10 SCN7A KIF4B ATP1A1 ATP1A3 ATP12A	7.32e-06	163	179	8	DOID:1826 (implicated_via_orthology)
Disease	familial hemiplegic migraine (implicated_via_orthology)	ATP1A1 ATP1A3 ATP12A	7.55e-06	7	179	3	DOID:0060178 (implicated_via_orthology)
Disease	obsolete aging, epigenetic status	SEC16B STXBP4 PTPRT ZNF248 KIF13A	8.70e-06	46	179	5	EFO_0000473, GO_0007568
Disease	Autism Spectrum Disorders	SOX5 CTTNBP2 TRIP12 RYR2 JARID2 USH2A	1.35e-05	85	179	6	C1510586
Disease	Adenocarcinoma of large intestine	MCC MSH2 MET MSH6 EGFR ATM	2.70e-05	96	179	6	C1319315
Disease	Breast Cancer, Familial	MSH2 MSH6 ATM SLX4	3.17e-05	30	179	4	C0346153
Disease	nervous system disease (implicated_via_orthology)	ATP1A1 ATP1A3 ATP12A	4.64e-05	12	179	3	DOID:863 (implicated_via_orthology)
Disease	age at menarche	SOX5 SEC16B DSCAM RPAP3 MYO10 STXBP4 KDM3B THSD7B MSH6 NOSTRIN UNC79 SLX4 PML	7.42e-05	594	179	13	EFO_0004703
Disease	colorectal cancer (is_implicated_in)	AMER1 MCC MSH2 PTPRT EGFR ATM	9.89e-05	121	179	6	DOID:9256 (is_implicated_in)
Disease	Torre-Muir syndrome	MSH2 MSH6	1.09e-04	3	179	2	C1321489
Disease	Lynch syndrome (implicated_via_orthology)	MSH2 MSH6	1.09e-04	3	179	2	DOID:3883 (implicated_via_orthology)
Disease	Malignant neoplasm of endometrium	MSH2 MSH6 EGFR	1.68e-04	18	179	3	C0007103
Disease	Carcinoma in situ of endometrium	MSH2 MSH6 EGFR	1.68e-04	18	179	3	C0346191
Disease	familial non-medullary thyroid cancer	MSH2 MSH6	2.18e-04	4	179	2	C4733333
Disease	Constitutional Mismatch Repair Deficiency Syndrome	MSH2 MSH6	2.18e-04	4	179	2	C4321324
Disease	Turcot syndrome	MSH2 MSH6	2.18e-04	4	179	2	cv:C0265325
Disease	Gilles de la Tourette syndrome (implicated_via_orthology)	MET HDC	2.18e-04	4	179	2	DOID:11119 (implicated_via_orthology)
Disease	Lynch syndrome	MSH2 MSH6	2.18e-04	4	179	2	cv:C4552100
Disease	Turcot syndrome (disorder)	MSH2 MSH6	3.62e-04	5	179	2	C0265325
Disease	corpus callosum volume measurement	CTTNBP2 TG ENO4 EGFR TLN1	3.67e-04	100	179	5	EFO_0010299
Disease	Hereditary Nonpolyposis Colorectal Neoplasms	MSH2 MSH6 ATM	5.15e-04	26	179	3	C0009405
Disease	aortic valve disease (implicated_via_orthology)	EGFR RBPJ	5.40e-04	6	179	2	DOID:62 (implicated_via_orthology)
Disease	beta-hydroxybutyric acid measurement	THSD7B NOSTRIN	5.40e-04	6	179	2	EFO_0010465
Disease	Adult only	MSH2 MSH6	5.40e-04	6	179	2	C3842001
Disease	retinitis pigmentosa (implicated_via_orthology)	EYS CCDC66 USH2A	5.77e-04	27	179	3	DOID:10584 (implicated_via_orthology)
Disease	Hereditary non-polyposis colorectal cancer syndrome	MSH2 MSH6 ATM	5.77e-04	27	179	3	C1112155
Disease	lung non-small cell carcinoma (is_marker_for)	L1CAM KDM3B MSH2 MET EGFR ATM	5.99e-04	169	179	6	DOID:3908 (is_marker_for)
Disease	breast carcinoma (is_marker_for)	MSH2 MSH6 EGFR ATM	7.04e-04	66	179	4	DOID:3459 (is_marker_for)
Disease	Hereditary Nonpolyposis Colorectal Cancer	MSH2 MSH6 ATM	7.14e-04	29	179	3	C1333990
Disease	Rectal Neoplasms	MCC EGFR	7.53e-04	7	179	2	C0034885
Disease	Rectal Carcinoma	MCC EGFR	7.53e-04	7	179	2	C0007113
Disease	pyridoxate measurement	SHROOM3 EMILIN2 THSD7B	8.71e-04	31	179	3	EFO_0010527
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	SOX5 JCAD KDM3A CTTNBP2 MAPT THSD7B FAM186B RYR2 MET MSH6 CAMTA1 USH2A UNC79	1.27e-03	801	179	13	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	Lynch Syndrome	MSH2 MSH6	1.28e-03	9	179	2	C4552100
Disease	hoarding disorder	SOX5 MSH6 TLN2	1.35e-03	36	179	3	EFO_0803361
Disease	tauopathy (implicated_via_orthology)	MAP4 MAPT	1.59e-03	10	179	2	DOID:680 (implicated_via_orthology)
Disease	diet measurement	SOX5 TDRD15 SEC16B CTTNBP2 ANK3 DSCAM KDM3B TEX15 THSD7B FAM186B PTPRT NBAS MSH6 BTN2A3P CAMTA1	1.91e-03	1049	179	15	EFO_0008111
Disease	senile cataract (is_implicated_in)	WRN ATM	1.94e-03	11	179	2	DOID:9669 (is_implicated_in)
Disease	osteosarcoma (is_marker_for)	MSH2 MSH6	1.94e-03	11	179	2	DOID:3347 (is_marker_for)
Disease	middle temporal gyrus volume measurement	OR13C3 OR13C4	1.94e-03	11	179	2	EFO_0010316
Disease	Cognitive impairment	PTPRT RYR2	1.94e-03	11	179	2	HP_0100543
Disease	mismatch repair cancer syndrome (is_implicated_in)	MSH2 MSH6	2.32e-03	12	179	2	DOID:0112182 (is_implicated_in)
Disease	colorectal cancer (is_marker_for)	AMER1 L1CAM KDM3B EGFR ATM	2.76e-03	157	179	5	DOID:9256 (is_marker_for)
Disease	Osteosarcoma	WRN MET EGFR	2.93e-03	47	179	3	C0029463
Disease	Alzheimer disease, APOE carrier status	SETX DSCAM NBAS FAM210B	3.04e-03	98	179	4	EFO_0007659, MONDO_0004975
Disease	Fanconi anemia	FANCB SLX4	3.17e-03	14	179	2	cv:C0015625
Disease	pimelic acid measurement, 3-methyladipic acid measurement	KIAA0232 USP1	3.17e-03	14	179	2	EFO_0010449, EFO_0010524
Disease	Down syndrome (implicated_via_orthology)	DSCAM DYRK3	3.65e-03	15	179	2	DOID:14250 (implicated_via_orthology)
Disease	Colorectal Carcinoma	WRN OBSCN MCC CHD1 MSH2 PTPRT MSH6 KCNA10 EGFR FBXL2 HDC	3.87e-03	702	179	11	C0009402
Disease	Squamous cell carcinoma of the head and neck	NSDHL MET EGFR	3.90e-03	52	179	3	C1168401
Disease	abdominal adipose tissue measurement	TLN2 ATP1A1 ATP1A3	4.12e-03	53	179	3	EFO_0803316
Disease	Abnormal behavior	KDM3B MED12L	4.15e-03	16	179	2	C0233514
Disease	Polyposis, Adenomatous Intestinal	MCC EGFR	4.15e-03	16	179	2	C2713442
Disease	Familial Intestinal Polyposis	MCC EGFR	4.15e-03	16	179	2	C2713443
Disease	Malignant mesothelioma	RYR2 MET MTMR4 EGFR	4.44e-03	109	179	4	C0345967
Disease	Myocardial Ischemia	CTTNBP2 PFKM RYR2 FABP5 ATP1A1	4.48e-03	176	179	5	C0151744
Disease	response to antidepressant	SOX5 MYO10 FAM98A ZNF248 EGFR	4.48e-03	176	179	5	GO_0036276
Disease	phenylalanine measurement	WDHD1 KIF13A KLKB1	4.57e-03	55	179	3	EFO_0005001
Disease	Benign neoplasm of stomach	MET ATM	4.69e-03	17	179	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	MET ATM	4.69e-03	17	179	2	C0496905
Disease	Carcinoma in situ of stomach	MET ATM	4.69e-03	17	179	2	C0154060
Disease	Adenomatous Polyposis Coli	MCC EGFR	4.69e-03	17	179	2	C0032580
Disease	methylcobalamin deficiency type cblE, overall survival, ovarian carcinoma, response to cisplatin	PDSS1 FABP5	4.69e-03	17	179	2	EFO_0000638, EFO_0001075, GO_0072718, MONDO_0009354
Disease	Bone marrow hypocellularity	FANCB SLX4	5.25e-03	18	179	2	C1855710
Disease	Carcinoma of bladder	ATM PEAK1	5.25e-03	18	179	2	C0699885
Disease	neuroimaging measurement	SOX5 SHROOM3 CTTNBP2 ANK3 MAPT FAM98A TG ENO4 ZNF106 EGFR TLN2 SSH2 NOSTRIN CAMTA1	5.80e-03	1069	179	14	EFO_0004346
Disease	laryngeal squamous cell carcinoma (is_marker_for)	MSH2 EGFR	5.85e-03	19	179	2	DOID:2876 (is_marker_for)
Disease	facial asymmetry measurement	SOX5 MYO10	5.85e-03	19	179	2	EFO_0009751
Disease	Colorectal cancer, hereditary nonpolyposis, type 1	MSH2 ATM	5.85e-03	19	179	2	C2936783

Protein segments in the cluster

Peptide	Gene	Start	Entry
SCSINDTLLGQKKES	BTN2A3P	216	Q96KV6
KKTLDCGSQTDQVTT	CEP152	786	O94986
KTSRKSVSQSVFCGT	CAMTA1	11	Q9Y6Y1
ASSRSKKLCDVTTGL	CFAP97	96	Q9P2B7
SASGPTKNVKTTTNC	ADGRG4	1776	Q8IZF6
TTTEAKALVKENGSC	ATP13A3	1206	Q9H7F0
CIRNSSTKSGKVLVV	SH3BP2	486	P78314
VSLSKSKNATAACGR	ANKRD62	416	A6NC57
STLKKALGLQSASCT	CHIA	381	Q9BZP6
ATLQCLGSDSKVKVN	C17orf78	66	Q8N4C9
NSKVKTASKLCSALT	CIAPIN1	106	Q6FI81
SRCKTSVAGATEKAV	AMER1	141	Q5JTC6
CSTLIEGQKKRSQVS	FAM186B	156	Q8IYM0
SELQALGKTGIKTSC	HSD17B13	201	Q7Z5P4
CIKALKDSSSGTERT	CHD1	1176	O14646
NETLTSCTKEVGKAA	DNAJC2	396	Q99543
TTSGVCVKKIRALAN	ARMCX2	601	Q7L311
QTKAVESGLKFSTQC	C9orf152	186	Q5JTZ5
KSKCNALVTSVDSAP	RAD51AP1	251	Q96B01
SLKNTDLCISSGSKV	RBPJL	201	Q9UBG7
EKVTFNLSKGACSSS	KIN	201	O60870
SRGVCKTKSVSENET	CACNG2	36	Q9Y698
QTKKKTVRSLSCNSV	HDC	576	P19113
DLTSCVSITNSSLKG	FBXL2	136	Q9UKC9
ISKKRNISFSGCAVQ	OR13C4	86	Q8NGS5
KSCGKSISIETANLR	MED12L	1226	Q86YW9
DISKVSSKCGSKANI	MAP4	1031	P27816
GTSTQCKIKINDCTS	EYS	1071	Q5T1H1
KAGTSSLTECVLNKA	IL15RA	66	Q13261
SIICSDKTGTLTQNR	ATP12A	386	P54707
STICSDKTGTLTQNR	ATP1A1	371	P05023
SQGESTCETQTKLKK	JCAD	546	Q9P266
DSSNKLICTKSKGSE	EXD1	406	Q8NHP7
QSRCKTAASRSGLSK	KRT80	406	Q6KB66
SSGSALAANVCKKIT	CAND1	121	Q86VP6
SSSSSSGSVKQLCKR	KIAA0232	351	Q92628
VNSLLDSTTISKAGC	OR14C36	81	Q8NHC7
LSQKGRQKALSTCSS	OR4A47	226	Q6IF82
TTCDRIKQSAAGTKR	PFKM	551	P08237
DNTTSKTTDCLQTKG	PEAK1	676	Q9H792
KTTDCLQTKGFSNST	PEAK1	681	Q9H792
TGSSVSCTEEKKQSK	FAM210B	71	Q96KR6
GSSDKICTSSLQVQR	EBLN2	196	Q6P2I7
SSATINKRLCKSTIE	DEPDC1	556	Q5TB30
VSSRNNQDTLKCGSK	MYO10	591	Q9HD67
CQEGTLKRKTSSVSS	PI4KA	246	P42356
SFKQSLESLSSGLCK	KDM3B	556	Q7LBC6
TNVLQSNSTKKCGID	KIAA0408	241	Q6ZU52
STIEKKGSRVTFTCQ	L1CAM	526	P32004
QKGKDLALTCQSTTS	NLRP4	356	Q96MN2
LTGDKLETATCTAKN	ATP9A	676	O75110
NSISSESIVQGFKKC	POGK	556	Q9P215
KTILKSSLSCSLQEG	MSH6	606	P52701
CSGALTVSSVKTLKN	NBAS	406	A2RRP1
TCDGKNLTIKTESTL	FABP5	46	Q01469
VSALSKVISNKCDGV	MTMR4	761	Q9NYA4
IPSSQQRKKAFSTCS	OR6C74	226	A6NCV1
KINCVRLATKGASTQ	PTPRT	716	O14522
QRCEVSKGKSSVVAA	FANCB	786	Q8NB91
ILCDLTKTKGSGNTV	ICOS	61	Q9Y6W8
GTCSSEAQLKVTAKN	OBSCN	4326	Q5VST9
SLNKTNGGCSTEKSR	KCNA10	496	Q16322
TSCLKETLSGLAKNA	PEX19	126	P40855
QQGSEDNLKTSTTKC	BOD1L1	2556	Q8NFC6
DNLKTSTTKCITGQE	BOD1L1	2561	Q8NFC6
SRSRQSKVELACGKS	GNPTG	131	Q9UJJ9
ASRALEEKKVCQGTS	EGFR	21	P00533
SAAVTCLKNILATKT	ATM	1731	Q13315
NVVCGRKKSSCSLSV	MCC	171	P23508
KIVAQLGKSTALNCS	IGSF10	2346	Q6WRI0
ENNGTLVSKQAKSCS	KDM3A	266	Q9Y4C1
SCEINTKGTTKKQDT	DOCK11	736	Q5JSL3
KLGSQTLTKTCSKSQ	GIMAP2	51	Q9UG22
SKSPLQRSLSAKCVS	CIBAR1	241	A1XBS5
SKVAAAASCLSQKVL	CCNB2	306	O95067
NSTRKIKDTCIQSPS	CENPC	61	Q03188
TIQAAKTFGKSILCS	CDC7	436	O00311
QTTECSNSKSKTELG	CTTNBP2	1591	Q8WZ74
KTASLIANSCKAVSV	PDSS1	266	Q5T2R2
SGSNTVSKTRKLVAQ	CMYA5	276	Q8N3K9
EACKNTVTATAKSLG	FSCN3	31	Q9NQT6
STQDTCIGSEKLLQK	CCDC66	56	A2RUB6
CSQDKAKISLGSSID	CEP350	966	Q5VT06
GKNATTDALTSVLTK	ANK3	4146	Q12955
SGTSREKTACAINKV	FAM98B	286	Q52LJ0
DCLTDKSAKTRQGAL	IFRD2	146	Q12894
ESKSLVLKGCSNVSN	LYPD8	161	Q6UX82
STICSDKTGTLTQNR	ATP1A3	361	P13637
VSLVSCGKSSSGKLN	ENO4	281	A6NNW6
KLSRCLSKAAGQTAQ	KIF4B	401	Q2VIQ3
SQRNVCLLKTSESGT	KLKB1	251	P03952
TSNTKLLGCQSIEKF	AHCTF1	346	Q8WYP5
KTCSKLDSISGNLQR	EMILIN2	711	Q9BXX0
KNGTCKLLVATSVAA	DDX46	666	Q7L014
SFGGSVQLTKCTTIK	C4orf36	51	Q96KX1
SCAAAGVQTSSKKSL	CELSR3	1651	Q9NYQ7
RTSCSTGQREAKKTS	CELSR3	2706	Q9NYQ7
SKGCSLTKAQRDSIE	RYR2	2556	Q92736
TGSQSLAALLNKCKT	MSH2	321	P43246
SQGKSSDCLNTVKSN	DYRK3	116	O43781
INCRKSTTGKSTVTR	MUCL3	166	Q3MIW9
ISKKRNISFSGCAVQ	OR13C3	116	Q8NGS6
NASSSCQSTPRKGKT	JARID2	201	Q92833
LSKALQNTRKSCVSS	NOSTRIN	56	Q8IVI9
KINSTSGKQKALSTC	OR8H1	226	Q8NGG4
KDKSINCTSGQLSSD	MINAR1	456	Q9UPX6
SSQSIPEKNSKSLCR	KIF13A	1681	Q9H1H9
SVSASKELSRCLVKG	MS4A12	146	Q9NXJ0
TLSLSSTKDKGSQVC	MIGA1	136	Q8NAN2
RKVKSSVGSQVSLSC	DSCAM	321	O60469
SIGGKTCTLKSVSNS	MET	691	P08581
GTNSVICSKKDKQSV	MRPS31	61	Q92665
QTDKSSDCITKTTGL	RTN3	351	O95197
KTGTINGSLLCNKST	USH2A	851	O75445
GLQGKVAKCSTLSIS	SMIM34	96	A8MWV9
STVNSKCLLKTVGTQ	TDRD15	406	B5MCY1
RANSSVVSVNCKGKD	OGA	586	O60502
TSSGSIREKTACAIN	FAM98A	281	Q8NCA5
VKKTCGNKSSVNSTV	JAML	296	Q86YT9
LSSCITQGKDAAVSK	PML	386	P29590
GSCLKQSSKNIFTER	SETX	686	Q7Z333
KRKAIQRTVSSSGCE	SHROOM3	1716	Q8TF72
SGKGLSSQCSNTEKR	SEMG2	151	Q02383
TCKEAGVQKLILTSS	NSDHL	131	Q15738
ICSSSKRSKEEVGIN	WRN	1381	Q14191
ESNSSANKCLLKVAG	NAPA	156	P54920
GKLNSKVERSQSCSD	RNF169	281	Q8NCN4
SQKTVKNRSCVYGSS	SPATA31C1	1041	P0DKV0
SCGKKETSQRKDTTT	SWT1	6	Q5T5J6
KTNNDILSSCEIKTG	STXBP4	156	Q6ZWJ1
SCTTQRKLQEKSSGA	SLX4	1481	Q8IY92
QILASLQSCESSKSK	AGAP5	441	A6NIR3
SCSQRAVIFTTKRGK	CCL26	56	Q9Y258
LLCTVCKSGQTNKSS	TNFRSF10D	116	Q9UBN6
CKSGQTNKSSCTTTR	TNFRSF10D	121	Q9UBN6
RISSGENSACNKTKQ	TP53TG5	81	Q9Y2B4
CKETASKTLSRFGIQ	RNF213	3981	Q63HN8
KGTCRTPSVLSQQSK	UHRF1BP1L	436	A0JNW5
SKCGKAFTQSSNLTV	ZNF35	281	P13682
RECIKGVNAESSSKL	ZNF880	81	Q6PDB4
LKSGNKINSSSVCVS	TMIGD1	76	Q6UXZ0
TCRKETSATGINSLQ	TRIM13	56	O60858
AAPTCTSLSTRKNSK	SSH2	886	Q76I76
CSSIGKLSKSDEQLS	RAPGEF1	351	Q13905
SAALAKSLVKTATGC	SLC26A1	396	Q9H2B4
KSLVKTATGCRTQLS	SLC26A1	401	Q9H2B4
ANVIAATGTTSKKNS	RPAP3	466	Q9H6T3
KCTQDLGNSTKAVSS	TLN1	1086	Q9Y490
VCTKINKSSGIVEAS	RNF141	81	Q8WVD5
RAASTGKSKSPCQTL	TINF2	321	Q9BSI4
ALKSGKLVTAVSNNT	WDHD1	61	O75717
KVISTVKRKTSCSAS	RFPL3S	41	P0C7P2
LTTSKSGSCSLTNVK	SPATA31D1	1161	Q6ZQQ2
SKDLANICKTAATAG	TIMMDC1	71	Q9NPL8
SQCGKSFSQKATLVK	ZIK1	326	Q3SY52
KSSQKESAVQRSKSC	TNKS1BP1	1676	Q9C0C2
TTKCIATVNTKGENI	THOC3	131	Q96J01
DLSKVTSKCGSLGNI	MAPT	631	P10636
GTNKNRQKSASTLCL	RHPN2P1	541	A8MT19
ITVTGKKLTVTCSQN	TRBV27	31	A0A0K0K1C4
FKKLCLQSSGSVSSE	SLF1	686	Q9BQI6
QQKAAQSCKSETLGS	SEC16B	346	Q96JE7
KQSLKNADLCIASGT	RBPJ	171	Q06330
KECGKAFNQSSTLTI	ZNF730	371	Q6ZMV8
SSSQLECLSRKGQEK	ZDHHC23	206	Q8IYP9
SICGKTFNKSSQLIS	ZNF445	981	P59923
LEKCAQDLGSTSKAV	TLN2	1086	Q9Y4G6
SECGKVFSKSSTLNK	ZNF454	181	Q8N9F8
GSKEKIKQSSSSECS	SCN7A	861	Q01118
SLGLNNCRTEKEKTT	SOX5	486	P35711
KKVVFSSTSLGNCSI	TPTE2	421	Q6XPS3
SRSKTGSLQLICKSE	ZFP91	171	Q96JP5
LLLKDNVKGSSSETC	TEX15	1436	Q9BXT5
SCSNKNSDGKQTRSR	THSD7B	616	Q9C0I4
EECGKIITSSSNVAK	ZNF732	281	B4DXR9
AIKCSKNKSSSQEAV	TTC27	771	Q6P3X3
SQKRKRTESSCVKSG	TRIP12	146	Q14669
KSATSAKAGCSTITD	TRIP12	181	Q14669
TSKLGKQSSCEVSLL	TTLL4	1111	Q14679
NKCTALVKNKTAATT	TCFL5	236	Q9UL49
CSVRNSATGKESSKS	PSG5	301	Q15238
NSKATSFGSLRCQVK	TG	1651	P01266
KECGKSLSSNSVLIQ	ZNF619	331	Q8N2I2
VGAKNSRTQCSIKDN	ZNF512	26	Q96ME7
GQCGKSFIKNSSLTV	ZNF71	441	Q9NQZ8
TSKVNCLLVTQTSGK	ZNF106	1571	Q9H2Y7
TLSQKCKREASGTQS	TMEM234	146	Q8WY98
NACGKTFSQRSVLTK	ZNF248	551	Q8NDW4
ILSKFCSLGKITTNQ	USP1	351	O94782
EVADTTKLSSGSKRC	ZFYVE16	881	Q7Z3T8
TAETNKKDCQTGATS	ZNF114	271	Q8NC26
DKSCSTVTQLKEGLN	UNC79	591	Q9P2D8
RKTCSVSSSGSIKSA	ELFN2	626	Q5R3F8
KCSAIVQRAQSASKS	MORN4	126	Q8NDC4
LKENTSKSGLNLTCA	KLHL42	431	Q9P2K6
PCQSSTVKELSKTDR	MYO9A	1611	B2RTY4